nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—DRD4—obesity	0.0961	0.221	CbGaD
Apomorphine—HTR1B—obesity	0.0853	0.197	CbGaD
Apomorphine—DRD1—obesity	0.0813	0.187	CbGaD
Apomorphine—HTR2C—obesity	0.0696	0.16	CbGaD
Apomorphine—ADRA1B—Phendimetrazine—obesity	0.0682	0.196	CbGbCtD
Apomorphine—DRD1—Phenylpropanolamine—obesity	0.0615	0.177	CbGbCtD
Apomorphine—DRD2—obesity	0.0573	0.132	CbGaD
Apomorphine—ADRA2C—Methamphetamine—obesity	0.0516	0.148	CbGbCtD
Apomorphine—ADRA2B—Methamphetamine—obesity	0.0489	0.141	CbGbCtD
Apomorphine—HTR2A—obesity	0.0443	0.102	CbGaD
Apomorphine—ADRA2A—Benzphetamine—obesity	0.0426	0.123	CbGbCtD
Apomorphine—ADRA2A—Phenylpropanolamine—obesity	0.0406	0.117	CbGbCtD
Apomorphine—ADRA2A—Methamphetamine—obesity	0.034	0.0979	CbGbCtD
Apomorphine—Dyskinesia—Phenylpropanolamine—obesity	0.0016	0.0185	CcSEcCtD
Apomorphine—Yawning—Sibutramine—obesity	0.00158	0.0183	CcSEcCtD
Apomorphine—CALY—islet of Langerhans—obesity	0.00158	0.0985	CbGeAlD
Apomorphine—Psychotic disorder—Methamphetamine—obesity	0.00142	0.0164	CcSEcCtD
Apomorphine—Yawning—Bupropion—obesity	0.00138	0.0159	CcSEcCtD
Apomorphine—Psychotic disorder—Benzphetamine—obesity	0.00137	0.0159	CcSEcCtD
Apomorphine—Dyskinesia—Diethylpropion—obesity	0.00134	0.0154	CcSEcCtD
Apomorphine—HTR2A—sympathetic nervous system—obesity	0.0013	0.081	CbGeAlD
Apomorphine—HTR2A—vagus nerve—obesity	0.00126	0.0785	CbGeAlD
Apomorphine—Psychotic disorder—Phendimetrazine—obesity	0.00125	0.0145	CcSEcCtD
Apomorphine—Ecchymosis—Diethylpropion—obesity	0.00114	0.0131	CcSEcCtD
Apomorphine—Psychotic disorder—Phenylpropanolamine—obesity	0.00107	0.0123	CcSEcCtD
Apomorphine—Libido increased—Sibutramine—obesity	0.00105	0.0121	CcSEcCtD
Apomorphine—Psychotic disorder—Phentermine—obesity	0.00102	0.0118	CcSEcCtD
Apomorphine—CALY—pituitary gland—obesity	0.00101	0.0631	CbGeAlD
Apomorphine—Libido increased—Bupropion—obesity	0.000915	0.0106	CcSEcCtD
Apomorphine—Psychotic disorder—Diethylpropion—obesity	0.00089	0.0103	CcSEcCtD
Apomorphine—Angina pectoris—Phentermine—obesity	0.000882	0.0102	CcSEcCtD
Apomorphine—HTR2A—autonomic nervous system—obesity	0.000875	0.0545	CbGeAlD
Apomorphine—Psychotic disorder—Cimetidine—obesity	0.000847	0.00978	CcSEcCtD
Apomorphine—Drowsiness—Phenylpropanolamine—obesity	0.000844	0.00974	CcSEcCtD
Apomorphine—Flushing—Phendimetrazine—obesity	0.000823	0.0095	CcSEcCtD
Apomorphine—CALY—endocrine gland—obesity	0.000785	0.0489	CbGeAlD
Apomorphine—Sweating increased—Diethylpropion—obesity	0.000767	0.00886	CcSEcCtD
Apomorphine—Hallucination—Phenylpropanolamine—obesity	0.000754	0.0087	CcSEcCtD
Apomorphine—Contusion—Sibutramine—obesity	0.000732	0.00845	CcSEcCtD
Apomorphine—Hallucination—Phentermine—obesity	0.000721	0.00833	CcSEcCtD
Apomorphine—Flushing—Phenylpropanolamine—obesity	0.000703	0.00811	CcSEcCtD
Apomorphine—Drowsiness—Diethylpropion—obesity	0.000702	0.00811	CcSEcCtD
Apomorphine—Rhinorrhoea—Bupropion—obesity	0.000687	0.00793	CcSEcCtD
Apomorphine—Pneumonia—Cimetidine—obesity	0.000672	0.00776	CcSEcCtD
Apomorphine—Pallor—Bupropion—obesity	0.000671	0.00775	CcSEcCtD
Apomorphine—Drowsiness—Cimetidine—obesity	0.000668	0.00772	CcSEcCtD
Apomorphine—Hyperhidrosis—Benzphetamine—obesity	0.000668	0.00771	CcSEcCtD
Apomorphine—Insomnia—Methamphetamine—obesity	0.000648	0.00748	CcSEcCtD
Apomorphine—Contusion—Bupropion—obesity	0.000638	0.00736	CcSEcCtD
Apomorphine—Insomnia—Benzphetamine—obesity	0.000625	0.00722	CcSEcCtD
Apomorphine—HTR1A—hindbrain—obesity	0.000618	0.0385	CbGeAlD
Apomorphine—Constipation—Methamphetamine—obesity	0.000613	0.00708	CcSEcCtD
Apomorphine—Hyperhidrosis—Phendimetrazine—obesity	0.000609	0.00703	CcSEcCtD
Apomorphine—Hallucination—Cimetidine—obesity	0.000597	0.00689	CcSEcCtD
Apomorphine—Dyskinesia—Bupropion—obesity	0.000592	0.00684	CcSEcCtD
Apomorphine—Libido increased—Topiramate—obesity	0.000583	0.00673	CcSEcCtD
Apomorphine—Ecchymosis—Sibutramine—obesity	0.000577	0.00666	CcSEcCtD
Apomorphine—Insomnia—Phendimetrazine—obesity	0.00057	0.00658	CcSEcCtD
Apomorphine—Anxiety—Phenylpropanolamine—obesity	0.000559	0.00646	CcSEcCtD
Apomorphine—DRD2—hindbrain—obesity	0.000559	0.0348	CbGeAlD
Apomorphine—Confusional state—Phenylpropanolamine—obesity	0.000543	0.00626	CcSEcCtD
Apomorphine—Constipation—Phendimetrazine—obesity	0.000539	0.00622	CcSEcCtD
Apomorphine—Chest pain—Phentermine—obesity	0.000537	0.0062	CcSEcCtD
Apomorphine—Oedema—Phentermine—obesity	0.000515	0.00594	CcSEcCtD
Apomorphine—Cardiac failure congestive—Sibutramine—obesity	0.000511	0.0059	CcSEcCtD
Apomorphine—Ecchymosis—Bupropion—obesity	0.000503	0.00581	CcSEcCtD
Apomorphine—Hypotension—Phenylpropanolamine—obesity	0.000503	0.0058	CcSEcCtD
Apomorphine—Diarrhoea—Methamphetamine—obesity	0.00049	0.00566	CcSEcCtD
Apomorphine—Insomnia—Phenylpropanolamine—obesity	0.000487	0.00562	CcSEcCtD
Apomorphine—Dyspnoea—Phenylpropanolamine—obesity	0.00048	0.00554	CcSEcCtD
Apomorphine—Somnolence—Phenylpropanolamine—obesity	0.000478	0.00552	CcSEcCtD
Apomorphine—Dizziness—Methamphetamine—obesity	0.000474	0.00547	CcSEcCtD
Apomorphine—Diarrhoea—Benzphetamine—obesity	0.000473	0.00546	CcSEcCtD
Apomorphine—Chest pain—Diethylpropion—obesity	0.000467	0.00539	CcSEcCtD
Apomorphine—Insomnia—Phentermine—obesity	0.000466	0.00538	CcSEcCtD
Apomorphine—Anxiety—Diethylpropion—obesity	0.000466	0.00538	CcSEcCtD
Apomorphine—Pain in extremity—Sibutramine—obesity	0.000463	0.00535	CcSEcCtD
Apomorphine—Constipation—Phenylpropanolamine—obesity	0.00046	0.00531	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Sibutramine—obesity	0.00046	0.00531	CcSEcCtD
Apomorphine—Dizziness—Benzphetamine—obesity	0.000457	0.00528	CcSEcCtD
Apomorphine—Psychotic disorder—Sibutramine—obesity	0.000453	0.00522	CcSEcCtD
Apomorphine—Headache—Methamphetamine—obesity	0.000449	0.00518	CcSEcCtD
Apomorphine—Arthralgia—Cimetidine—obesity	0.000445	0.00513	CcSEcCtD
Apomorphine—Fatigue—Phentermine—obesity	0.000444	0.00513	CcSEcCtD
Apomorphine—Feeling abnormal—Phenylpropanolamine—obesity	0.000443	0.00512	CcSEcCtD
Apomorphine—Anxiety—Cimetidine—obesity	0.000443	0.00512	CcSEcCtD
Apomorphine—Constipation—Phentermine—obesity	0.00044	0.00508	CcSEcCtD
Apomorphine—Rhinorrhoea—Topiramate—obesity	0.000438	0.00505	CcSEcCtD
Apomorphine—Hyperhidrosis—Diethylpropion—obesity	0.000433	0.005	CcSEcCtD
Apomorphine—Headache—Benzphetamine—obesity	0.000433	0.005	CcSEcCtD
Apomorphine—Diarrhoea—Phendimetrazine—obesity	0.000431	0.00498	CcSEcCtD
Apomorphine—Dehydration—Sibutramine—obesity	0.000431	0.00497	CcSEcCtD
Apomorphine—Confusional state—Cimetidine—obesity	0.00043	0.00496	CcSEcCtD
Apomorphine—Pallor—Topiramate—obesity	0.000428	0.00494	CcSEcCtD
Apomorphine—Orthostatic hypotension—Sibutramine—obesity	0.000423	0.00489	CcSEcCtD
Apomorphine—Dizziness—Phendimetrazine—obesity	0.000417	0.00481	CcSEcCtD
Apomorphine—Nausea—Benzphetamine—obesity	0.000411	0.00474	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000408	0.00471	CcSEcCtD
Apomorphine—Insomnia—Diethylpropion—obesity	0.000405	0.00468	CcSEcCtD
Apomorphine—Pain in extremity—Bupropion—obesity	0.000404	0.00466	CcSEcCtD
Apomorphine—Sweating increased—Orlistat—obesity	0.000403	0.00465	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Bupropion—obesity	0.000401	0.00463	CcSEcCtD
Apomorphine—Dyspnoea—Diethylpropion—obesity	0.000399	0.00461	CcSEcCtD
Apomorphine—Somnolence—Diethylpropion—obesity	0.000398	0.0046	CcSEcCtD
Apomorphine—DRD5—endocrine gland—obesity	0.000397	0.0247	CbGeAlD
Apomorphine—Headache—Phendimetrazine—obesity	0.000395	0.00456	CcSEcCtD
Apomorphine—Psychotic disorder—Bupropion—obesity	0.000395	0.00455	CcSEcCtD
Apomorphine—Angina pectoris—Sibutramine—obesity	0.00039	0.0045	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Cimetidine—obesity	0.000388	0.00448	CcSEcCtD
Apomorphine—Constipation—Diethylpropion—obesity	0.000383	0.00442	CcSEcCtD
Apomorphine—Somnolence—Cimetidine—obesity	0.000379	0.00437	CcSEcCtD
Apomorphine—Dyskinesia—Topiramate—obesity	0.000377	0.00436	CcSEcCtD
Apomorphine—Dehydration—Bupropion—obesity	0.000376	0.00434	CcSEcCtD
Apomorphine—Nausea—Phendimetrazine—obesity	0.000374	0.00432	CcSEcCtD
Apomorphine—Asthenia—Phentermine—obesity	0.000369	0.00427	CcSEcCtD
Apomorphine—Feeling abnormal—Diethylpropion—obesity	0.000369	0.00426	CcSEcCtD
Apomorphine—Orthostatic hypotension—Bupropion—obesity	0.000369	0.00426	CcSEcCtD
Apomorphine—HTR2A—hindbrain—obesity	0.000368	0.0229	CbGeAlD
Apomorphine—Fatigue—Cimetidine—obesity	0.000367	0.00424	CcSEcCtD
Apomorphine—Constipation—Cimetidine—obesity	0.000365	0.00421	CcSEcCtD
Apomorphine—Nasopharyngitis—Bupropion—obesity	0.000361	0.00417	CcSEcCtD
Apomorphine—Pneumonia—Sibutramine—obesity	0.000359	0.00415	CcSEcCtD
Apomorphine—Urinary tract infection—Orlistat—obesity	0.000359	0.00414	CcSEcCtD
Apomorphine—HTR1B—cardiovascular system—obesity	0.000358	0.0223	CbGeAlD
Apomorphine—Dizziness—Phenylpropanolamine—obesity	0.000356	0.00411	CcSEcCtD
Apomorphine—HTR2B—adrenal cortex—obesity	0.000354	0.022	CbGeAlD
Apomorphine—Diarrhoea—Phentermine—obesity	0.000352	0.00407	CcSEcCtD
Apomorphine—Feeling abnormal—Cimetidine—obesity	0.000351	0.00405	CcSEcCtD
Apomorphine—Urinary tract infection—Sibutramine—obesity	0.000347	0.00401	CcSEcCtD
Apomorphine—HTR1D—cardiovascular system—obesity	0.000347	0.0216	CbGeAlD
Apomorphine—Vomiting—Phenylpropanolamine—obesity	0.000342	0.00395	CcSEcCtD
Apomorphine—DRD2—respiratory system—obesity	0.000341	0.0212	CbGeAlD
Apomorphine—Dizziness—Phentermine—obesity	0.000341	0.00393	CcSEcCtD
Apomorphine—Sweating increased—Bupropion—obesity	0.00034	0.00393	CcSEcCtD
Apomorphine—Vomiting—Phentermine—obesity	0.000327	0.00378	CcSEcCtD
Apomorphine—HTR2B—cardiovascular system—obesity	0.000323	0.0201	CbGeAlD
Apomorphine—Headache—Phentermine—obesity	0.000323	0.00372	CcSEcCtD
Apomorphine—Nausea—Phenylpropanolamine—obesity	0.00032	0.00369	CcSEcCtD
Apomorphine—ADRA1D—endocrine gland—obesity	0.000318	0.0198	CbGeAlD
Apomorphine—Pneumonia—Bupropion—obesity	0.000313	0.00361	CcSEcCtD
Apomorphine—Diarrhoea—Diethylpropion—obesity	0.000307	0.00354	CcSEcCtD
Apomorphine—Nausea—Phentermine—obesity	0.000306	0.00353	CcSEcCtD
Apomorphine—Asthenia—Cimetidine—obesity	0.000306	0.00353	CcSEcCtD
Apomorphine—Urinary tract infection—Bupropion—obesity	0.000303	0.00349	CcSEcCtD
Apomorphine—Dizziness—Diethylpropion—obesity	0.000296	0.00342	CcSEcCtD
Apomorphine—Diarrhoea—Cimetidine—obesity	0.000292	0.00337	CcSEcCtD
Apomorphine—Mental disorder—Orlistat—obesity	0.00029	0.00335	CcSEcCtD
Apomorphine—HTR1A—cardiovascular system—obesity	0.000289	0.018	CbGeAlD
Apomorphine—Vomiting—Diethylpropion—obesity	0.000285	0.00329	CcSEcCtD
Apomorphine—HTR2B—adipose tissue—obesity	0.000285	0.0177	CbGeAlD
Apomorphine—Dizziness—Cimetidine—obesity	0.000282	0.00325	CcSEcCtD
Apomorphine—Headache—Diethylpropion—obesity	0.000281	0.00324	CcSEcCtD
Apomorphine—ADRA2A—islet of Langerhans—obesity	0.00028	0.0175	CbGeAlD
Apomorphine—Back pain—Orlistat—obesity	0.000279	0.00322	CcSEcCtD
Apomorphine—ADRA2C—adrenal cortex—obesity	0.000278	0.0173	CbGeAlD
Apomorphine—Hallucination—Bupropion—obesity	0.000278	0.00321	CcSEcCtD
Apomorphine—Vomiting—Cimetidine—obesity	0.000271	0.00313	CcSEcCtD
Apomorphine—Back pain—Sibutramine—obesity	0.00027	0.00312	CcSEcCtD
Apomorphine—HTR2B—digestive system—obesity	0.000268	0.0167	CbGeAlD
Apomorphine—Headache—Cimetidine—obesity	0.000267	0.00308	CcSEcCtD
Apomorphine—Nausea—Diethylpropion—obesity	0.000266	0.00307	CcSEcCtD
Apomorphine—Flushing—Bupropion—obesity	0.000259	0.00299	CcSEcCtD
Apomorphine—Pain in extremity—Topiramate—obesity	0.000257	0.00297	CcSEcCtD
Apomorphine—Disturbance in sexual arousal—Topiramate—obesity	0.000255	0.00295	CcSEcCtD
Apomorphine—HTR2B—adrenal gland—obesity	0.000255	0.0159	CbGeAlD
Apomorphine—Nausea—Cimetidine—obesity	0.000253	0.00292	CcSEcCtD
Apomorphine—Psychotic disorder—Topiramate—obesity	0.000251	0.0029	CcSEcCtD
Apomorphine—Syncope—Sibutramine—obesity	0.00025	0.00289	CcSEcCtD
Apomorphine—HTR1B—endocrine gland—obesity	0.000246	0.0153	CbGeAlD
Apomorphine—Chest pain—Orlistat—obesity	0.000245	0.00283	CcSEcCtD
Apomorphine—Loss of consciousness—Sibutramine—obesity	0.000245	0.00283	CcSEcCtD
Apomorphine—Mental disorder—Bupropion—obesity	0.000245	0.00283	CcSEcCtD
Apomorphine—Anxiety—Orlistat—obesity	0.000245	0.00282	CcSEcCtD
Apomorphine—Dehydration—Topiramate—obesity	0.000239	0.00276	CcSEcCtD
Apomorphine—Chest pain—Sibutramine—obesity	0.000238	0.00274	CcSEcCtD
Apomorphine—Arthralgia—Sibutramine—obesity	0.000238	0.00274	CcSEcCtD
Apomorphine—Anxiety—Sibutramine—obesity	0.000237	0.00273	CcSEcCtD
Apomorphine—Oedema—Orlistat—obesity	0.000235	0.00272	CcSEcCtD
Apomorphine—Back pain—Bupropion—obesity	0.000235	0.00272	CcSEcCtD
Apomorphine—Orthostatic hypotension—Topiramate—obesity	0.000235	0.00271	CcSEcCtD
Apomorphine—DRD2—pituitary gland—obesity	0.000231	0.0144	CbGeAlD
Apomorphine—Nasopharyngitis—Topiramate—obesity	0.00023	0.00266	CcSEcCtD
Apomorphine—Confusional state—Sibutramine—obesity	0.00023	0.00265	CcSEcCtD
Apomorphine—HTR1A—adrenal gland—obesity	0.000229	0.0142	CbGeAlD
Apomorphine—Oedema—Sibutramine—obesity	0.000228	0.00263	CcSEcCtD
Apomorphine—Hyperhidrosis—Orlistat—obesity	0.000227	0.00263	CcSEcCtD
Apomorphine—HTR2A—respiratory system—obesity	0.000225	0.014	CbGeAlD
Apomorphine—ADRA2C—pituitary gland—obesity	0.000225	0.014	CbGeAlD
Apomorphine—Shock—Sibutramine—obesity	0.000224	0.00259	CcSEcCtD
Apomorphine—ADRA2C—adipose tissue—obesity	0.000224	0.0139	CbGeAlD
Apomorphine—Hyperhidrosis—Sibutramine—obesity	0.00022	0.00254	CcSEcCtD
Apomorphine—Syncope—Bupropion—obesity	0.000218	0.00252	CcSEcCtD
Apomorphine—Angina pectoris—Topiramate—obesity	0.000217	0.0025	CcSEcCtD
Apomorphine—Sweating increased—Topiramate—obesity	0.000217	0.0025	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Orlistat—obesity	0.000214	0.00248	CcSEcCtD
Apomorphine—Loss of consciousness—Bupropion—obesity	0.000214	0.00247	CcSEcCtD
Apomorphine—Insomnia—Orlistat—obesity	0.000213	0.00246	CcSEcCtD
Apomorphine—Hypotension—Sibutramine—obesity	0.000213	0.00246	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Sibutramine—obesity	0.000207	0.0024	CcSEcCtD
Apomorphine—Arthralgia—Bupropion—obesity	0.000207	0.00239	CcSEcCtD
Apomorphine—Chest pain—Bupropion—obesity	0.000207	0.00239	CcSEcCtD
Apomorphine—Anxiety—Bupropion—obesity	0.000206	0.00238	CcSEcCtD
Apomorphine—Insomnia—Sibutramine—obesity	0.000206	0.00238	CcSEcCtD
Apomorphine—Dyspnoea—Sibutramine—obesity	0.000203	0.00234	CcSEcCtD
Apomorphine—Fatigue—Orlistat—obesity	0.000203	0.00234	CcSEcCtD
Apomorphine—Somnolence—Sibutramine—obesity	0.000202	0.00234	CcSEcCtD
Apomorphine—ADRA2C—adrenal gland—obesity	0.000201	0.0125	CbGeAlD
Apomorphine—Confusional state—Bupropion—obesity	0.0002	0.00231	CcSEcCtD
Apomorphine—Pneumonia—Topiramate—obesity	0.000199	0.0023	CcSEcCtD
Apomorphine—Oedema—Bupropion—obesity	0.000199	0.00229	CcSEcCtD
Apomorphine—HTR1A—endocrine gland—obesity	0.000198	0.0124	CbGeAlD
Apomorphine—Shock—Bupropion—obesity	0.000195	0.00225	CcSEcCtD
Apomorphine—Constipation—Sibutramine—obesity	0.000195	0.00225	CcSEcCtD
Apomorphine—Feeling abnormal—Orlistat—obesity	0.000194	0.00224	CcSEcCtD
Apomorphine—Urinary tract infection—Topiramate—obesity	0.000193	0.00223	CcSEcCtD
Apomorphine—Hyperhidrosis—Bupropion—obesity	0.000192	0.00222	CcSEcCtD
Apomorphine—Feeling abnormal—Sibutramine—obesity	0.000188	0.00217	CcSEcCtD
Apomorphine—Hypotension—Bupropion—obesity	0.000186	0.00214	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Bupropion—obesity	0.000181	0.00209	CcSEcCtD
Apomorphine—Insomnia—Bupropion—obesity	0.00018	0.00207	CcSEcCtD
Apomorphine—ADRA2A—pituitary gland—obesity	0.000179	0.0112	CbGeAlD
Apomorphine—DRD2—endocrine gland—obesity	0.000179	0.0112	CbGeAlD
Apomorphine—ADRA2A—adipose tissue—obesity	0.000179	0.0111	CbGeAlD
Apomorphine—Hallucination—Topiramate—obesity	0.000177	0.00205	CcSEcCtD
Apomorphine—Dyspnoea—Bupropion—obesity	0.000177	0.00204	CcSEcCtD
Apomorphine—Somnolence—Bupropion—obesity	0.000177	0.00204	CcSEcCtD
Apomorphine—HTR2A—cardiovascular system—obesity	0.000172	0.0107	CbGeAlD
Apomorphine—Fatigue—Bupropion—obesity	0.000171	0.00198	CcSEcCtD
Apomorphine—Constipation—Bupropion—obesity	0.00017	0.00196	CcSEcCtD
Apomorphine—Asthenia—Orlistat—obesity	0.000169	0.00195	CcSEcCtD
Apomorphine—Pruritus—Orlistat—obesity	0.000166	0.00192	CcSEcCtD
Apomorphine—Flushing—Topiramate—obesity	0.000165	0.00191	CcSEcCtD
Apomorphine—Feeling abnormal—Bupropion—obesity	0.000164	0.00189	CcSEcCtD
Apomorphine—Asthenia—Sibutramine—obesity	0.000163	0.00189	CcSEcCtD
Apomorphine—Pruritus—Sibutramine—obesity	0.000161	0.00186	CcSEcCtD
Apomorphine—Diarrhoea—Orlistat—obesity	0.000161	0.00186	CcSEcCtD
Apomorphine—ADRA2A—adrenal gland—obesity	0.00016	0.00998	CbGeAlD
Apomorphine—ADRA2C—liver—obesity	0.000157	0.00978	CbGeAlD
Apomorphine—Mental disorder—Topiramate—obesity	0.000156	0.0018	CcSEcCtD
Apomorphine—Diarrhoea—Sibutramine—obesity	0.000156	0.0018	CcSEcCtD
Apomorphine—Dizziness—Orlistat—obesity	0.000156	0.0018	CcSEcCtD
Apomorphine—HTR2A—pituitary gland—obesity	0.000153	0.0095	CbGeAlD
Apomorphine—Dizziness—Sibutramine—obesity	0.000151	0.00174	CcSEcCtD
Apomorphine—Back pain—Topiramate—obesity	0.00015	0.00173	CcSEcCtD
Apomorphine—Vomiting—Orlistat—obesity	0.00015	0.00173	CcSEcCtD
Apomorphine—Headache—Orlistat—obesity	0.000147	0.0017	CcSEcCtD
Apomorphine—Vomiting—Sibutramine—obesity	0.000145	0.00167	CcSEcCtD
Apomorphine—HTR2A—digestive system—obesity	0.000143	0.00891	CbGeAlD
Apomorphine—Headache—Sibutramine—obesity	0.000143	0.00165	CcSEcCtD
Apomorphine—Asthenia—Bupropion—obesity	0.000142	0.00164	CcSEcCtD
Apomorphine—Pruritus—Bupropion—obesity	0.00014	0.00162	CcSEcCtD
Apomorphine—Nausea—Orlistat—obesity	0.00014	0.00161	CcSEcCtD
Apomorphine—ADRA2A—endocrine gland—obesity	0.000139	0.00866	CbGeAlD
Apomorphine—Syncope—Topiramate—obesity	0.000139	0.0016	CcSEcCtD
Apomorphine—HTR2A—adrenal gland—obesity	0.000136	0.00849	CbGeAlD
Apomorphine—Loss of consciousness—Topiramate—obesity	0.000136	0.00157	CcSEcCtD
Apomorphine—Diarrhoea—Bupropion—obesity	0.000136	0.00157	CcSEcCtD
Apomorphine—Nausea—Sibutramine—obesity	0.000135	0.00156	CcSEcCtD
Apomorphine—Chest pain—Topiramate—obesity	0.000132	0.00152	CcSEcCtD
Apomorphine—Arthralgia—Topiramate—obesity	0.000132	0.00152	CcSEcCtD
Apomorphine—Anxiety—Topiramate—obesity	0.000131	0.00152	CcSEcCtD
Apomorphine—Dizziness—Bupropion—obesity	0.000131	0.00152	CcSEcCtD
Apomorphine—Confusional state—Topiramate—obesity	0.000128	0.00147	CcSEcCtD
Apomorphine—Oedema—Topiramate—obesity	0.000126	0.00146	CcSEcCtD
Apomorphine—Vomiting—Bupropion—obesity	0.000126	0.00146	CcSEcCtD
Apomorphine—Shock—Topiramate—obesity	0.000124	0.00144	CcSEcCtD
Apomorphine—Headache—Bupropion—obesity	0.000124	0.00144	CcSEcCtD
Apomorphine—Hyperhidrosis—Topiramate—obesity	0.000122	0.00141	CcSEcCtD
Apomorphine—HTR2A—endocrine gland—obesity	0.000118	0.00736	CbGeAlD
Apomorphine—Hypotension—Topiramate—obesity	0.000118	0.00136	CcSEcCtD
Apomorphine—Nausea—Bupropion—obesity	0.000118	0.00136	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Topiramate—obesity	0.000115	0.00133	CcSEcCtD
Apomorphine—Insomnia—Topiramate—obesity	0.000114	0.00132	CcSEcCtD
Apomorphine—Dyspnoea—Topiramate—obesity	0.000113	0.0013	CcSEcCtD
Apomorphine—Somnolence—Topiramate—obesity	0.000112	0.0013	CcSEcCtD
Apomorphine—Fatigue—Topiramate—obesity	0.000109	0.00126	CcSEcCtD
Apomorphine—Constipation—Topiramate—obesity	0.000108	0.00125	CcSEcCtD
Apomorphine—HTR2A—liver—obesity	0.000107	0.00664	CbGeAlD
Apomorphine—Feeling abnormal—Topiramate—obesity	0.000104	0.0012	CcSEcCtD
Apomorphine—Asthenia—Topiramate—obesity	9.08e-05	0.00105	CcSEcCtD
Apomorphine—Pruritus—Topiramate—obesity	8.95e-05	0.00103	CcSEcCtD
Apomorphine—Diarrhoea—Topiramate—obesity	8.65e-05	0.000999	CcSEcCtD
Apomorphine—Dizziness—Topiramate—obesity	8.36e-05	0.000966	CcSEcCtD
Apomorphine—Vomiting—Topiramate—obesity	8.04e-05	0.000928	CcSEcCtD
Apomorphine—Headache—Topiramate—obesity	7.92e-05	0.000915	CcSEcCtD
Apomorphine—Nausea—Topiramate—obesity	7.51e-05	0.000867	CcSEcCtD
Apomorphine—HTR1A—Signaling Pathways—TYK2—obesity	1.29e-06	1.11e-05	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	1.29e-06	1.11e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TYK2—obesity	1.29e-06	1.11e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SERPINE1—obesity	1.29e-06	1.11e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—RHOA—obesity	1.28e-06	1.1e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CD—obesity	1.28e-06	1.1e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MAPK8—obesity	1.28e-06	1.1e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—POMC—obesity	1.28e-06	1.1e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RHOA—obesity	1.28e-06	1.1e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—AKT1—obesity	1.28e-06	1.1e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ESR1—obesity	1.27e-06	1.09e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—INS—obesity	1.27e-06	1.09e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—NOS3—obesity	1.27e-06	1.09e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3R1—obesity	1.27e-06	1.09e-05	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	1.27e-06	1.09e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SERPINE1—obesity	1.27e-06	1.09e-05	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—AKT1—obesity	1.26e-06	1.09e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CD—obesity	1.26e-06	1.09e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3R1—obesity	1.26e-06	1.09e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—NOS3—obesity	1.26e-06	1.09e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—POMC—obesity	1.26e-06	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PRKCB—obesity	1.26e-06	1.08e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MMP9—obesity	1.26e-06	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—F2—obesity	1.26e-06	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—PIK3CA—obesity	1.25e-06	1.08e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TYK2—obesity	1.25e-06	1.08e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—INS—obesity	1.25e-06	1.08e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCL2—obesity	1.25e-06	1.08e-05	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—PIK3CA—obesity	1.25e-06	1.08e-05	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—AKT1—obesity	1.25e-06	1.07e-05	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—AKT1—obesity	1.25e-06	1.07e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ALB—obesity	1.25e-06	1.07e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—obesity	1.24e-06	1.07e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RHOA—obesity	1.24e-06	1.07e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—BAD—obesity	1.24e-06	1.07e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TYK2—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCL2—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IGF1—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT2—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3R1—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—NOS3—obesity	1.23e-06	1.06e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RHOA—obesity	1.22e-06	1.05e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MAPK8—obesity	1.22e-06	1.05e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—AKT1—obesity	1.22e-06	1.05e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—STAT3—obesity	1.21e-06	1.05e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MTOR—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CB—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IGF1—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—PIK3CA—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—NOS3—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3R1—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT2—obesity	1.21e-06	1.04e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—PIK3CA—obesity	1.2e-06	1.04e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CG—obesity	1.2e-06	1.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3R1—obesity	1.19e-06	1.03e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—NOS3—obesity	1.19e-06	1.03e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—STAT3—obesity	1.19e-06	1.02e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS1—obesity	1.19e-06	1.02e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MMP9—obesity	1.18e-06	1.02e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CD—obesity	1.18e-06	1.02e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MTOR—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CB—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—PIK3CA—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—STAT3—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—PIK3CA—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MMP9—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MMP9—obesity	1.17e-06	1.01e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SERPINE1—obesity	1.17e-06	1e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MTOR—obesity	1.17e-06	1e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CB—obesity	1.17e-06	1e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CD—obesity	1.16e-06	1e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK8—obesity	1.15e-06	9.92e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	1.15e-06	9.91e-06	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—PIK3CA—obesity	1.15e-06	9.9e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—obesity	1.15e-06	9.89e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SERPINE1—obesity	1.15e-06	9.89e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—POMC—obesity	1.14e-06	9.85e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—INS—obesity	1.14e-06	9.79e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK8—obesity	1.14e-06	9.78e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK8—obesity	1.14e-06	9.78e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TYK2—obesity	1.14e-06	9.77e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CB—obesity	1.13e-06	9.76e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MTOR—obesity	1.13e-06	9.76e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—obesity	1.13e-06	9.76e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—obesity	1.13e-06	9.76e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—obesity	1.13e-06	9.71e-06	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.13e-06	9.7e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RHOA—obesity	1.13e-06	9.69e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TGFB1—obesity	1.12e-06	9.69e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL2—obesity	1.12e-06	9.64e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TYK2—obesity	1.12e-06	9.62e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—STAT3—obesity	1.12e-06	9.61e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CB—obesity	1.12e-06	9.61e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MTOR—obesity	1.12e-06	9.61e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NOS3—obesity	1.11e-06	9.59e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3R1—obesity	1.11e-06	9.59e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—obesity	1.11e-06	9.55e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RHOA—obesity	1.11e-06	9.54e-06	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—obesity	1.11e-06	9.53e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—obesity	1.1e-06	9.51e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TGFB1—obesity	1.1e-06	9.49e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CB—obesity	1.1e-06	9.48e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IGF1—obesity	1.1e-06	9.47e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT2—obesity	1.1e-06	9.47e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3R1—obesity	1.1e-06	9.44e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NOS3—obesity	1.1e-06	9.44e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—obesity	1.09e-06	9.39e-06	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—obesity	1.09e-06	9.36e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—obesity	1.09e-06	9.36e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—obesity	1.08e-06	9.33e-06	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—obesity	1.08e-06	9.32e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—obesity	1.07e-06	9.22e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—obesity	1.06e-06	9.17e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—PIK3CA—obesity	1.06e-06	9.14e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CD—obesity	1.06e-06	9.1e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—obesity	1.05e-06	9.08e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—STAT3—obesity	1.05e-06	9.07e-06	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—obesity	1.05e-06	9.06e-06	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	1.05e-06	9.01e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—obesity	1.04e-06	9e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—PIK3CA—obesity	1.04e-06	8.99e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—STAT3—obesity	1.04e-06	8.94e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—STAT3—obesity	1.04e-06	8.94e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—obesity	1.04e-06	8.93e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—obesity	1.04e-06	8.92e-06	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—obesity	1.04e-06	8.92e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—obesity	1.03e-06	8.91e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MTOR—obesity	1.03e-06	8.86e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CB—obesity	1.03e-06	8.86e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK8—obesity	1.03e-06	8.83e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—obesity	1.02e-06	8.81e-06	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—obesity	1.02e-06	8.79e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—obesity	1.02e-06	8.78e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—obesity	1.02e-06	8.77e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TYK2—obesity	1.02e-06	8.75e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—obesity	1.01e-06	8.72e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CB—obesity	1.01e-06	8.71e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MTOR—obesity	1.01e-06	8.71e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RHOA—obesity	1.01e-06	8.68e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOS3—obesity	9.97e-07	8.59e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3R1—obesity	9.97e-07	8.59e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK8—obesity	9.9e-07	8.53e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—obesity	9.87e-07	8.5e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—obesity	9.85e-07	8.48e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK8—obesity	9.85e-07	8.48e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—obesity	9.82e-07	8.46e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—obesity	9.78e-07	8.42e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—obesity	9.76e-07	8.4e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—obesity	9.7e-07	8.35e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—obesity	9.65e-07	8.31e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—obesity	9.65e-07	8.31e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—obesity	9.63e-07	8.29e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—obesity	9.63e-07	8.29e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK8—obesity	9.58e-07	8.25e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—PIK3CA—obesity	9.57e-07	8.24e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—obesity	9.55e-07	8.23e-06	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—obesity	9.55e-07	8.22e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	9.5e-07	8.18e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK8—obesity	9.43e-07	8.12e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—obesity	9.4e-07	8.1e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—obesity	9.4e-07	8.09e-06	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—obesity	9.39e-07	8.09e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—STAT3—obesity	9.38e-07	8.08e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—PIK3CA—obesity	9.37e-07	8.07e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—obesity	9.25e-07	7.96e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CA—obesity	9.22e-07	7.94e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MTOR—obesity	9.21e-07	7.93e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CB—obesity	9.21e-07	7.93e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—STAT3—obesity	9.05e-07	7.8e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—STAT3—obesity	9.01e-07	7.76e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—obesity	8.94e-07	7.7e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CA—obesity	8.8e-07	7.58e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—obesity	8.8e-07	7.57e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—STAT3—obesity	8.76e-07	7.54e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—obesity	8.71e-07	7.5e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK8—obesity	8.69e-07	7.49e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—obesity	8.69e-07	7.49e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—obesity	8.67e-07	7.47e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—STAT3—obesity	8.62e-07	7.42e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK8—obesity	8.55e-07	7.37e-06	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—obesity	8.55e-07	7.36e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—obesity	8.53e-07	7.35e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—obesity	8.48e-07	7.3e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—obesity	8.41e-07	7.24e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—obesity	8.41e-07	7.24e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—obesity	8.39e-07	7.23e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—obesity	8.37e-07	7.21e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—obesity	8.35e-07	7.19e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CA—obesity	8.3e-07	7.15e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—obesity	8.3e-07	7.15e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CA—obesity	8.26e-07	7.12e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CA—obesity	8.19e-07	7.06e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CA—obesity	8.19e-07	7.06e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—obesity	8.17e-07	7.03e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—obesity	8.14e-07	7.01e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—obesity	8.12e-07	6.99e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—obesity	8.01e-07	6.9e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—obesity	8e-07	6.89e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—obesity	7.99e-07	6.88e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—STAT3—obesity	7.95e-07	6.84e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—obesity	7.82e-07	6.73e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—STAT3—obesity	7.82e-07	6.73e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—obesity	7.8e-07	6.71e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK8—obesity	7.78e-07	6.7e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—obesity	7.76e-07	6.68e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—obesity	7.66e-07	6.59e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—obesity	7.53e-07	6.49e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CA—obesity	7.4e-07	6.37e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—obesity	7.38e-07	6.36e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—obesity	7.37e-07	6.34e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—obesity	7.35e-07	6.33e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—obesity	7.27e-07	6.26e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—obesity	7.25e-07	6.25e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—obesity	7.25e-07	6.25e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—obesity	7.25e-07	6.24e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—obesity	7.19e-07	6.19e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CA—obesity	7.14e-07	6.15e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—STAT3—obesity	7.11e-07	6.13e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CA—obesity	7.1e-07	6.12e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CA—obesity	6.91e-07	5.95e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CA—obesity	6.8e-07	5.86e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—obesity	6.78e-07	5.84e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—obesity	6.75e-07	5.81e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CA—obesity	6.71e-07	5.78e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—obesity	6.69e-07	5.76e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—obesity	6.69e-07	5.76e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—obesity	6.61e-07	5.69e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—obesity	6.59e-07	5.68e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—obesity	6.55e-07	5.64e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—obesity	6.32e-07	5.45e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—obesity	6.29e-07	5.42e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CA—obesity	6.27e-07	5.4e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CA—obesity	6.17e-07	5.31e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—obesity	6.12e-07	5.27e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—obesity	6.04e-07	5.2e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—obesity	6.02e-07	5.19e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—obesity	5.83e-07	5.02e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—obesity	5.8e-07	5e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—obesity	5.64e-07	4.86e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CA—obesity	5.61e-07	4.83e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—obesity	5.55e-07	4.78e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—obesity	5.55e-07	4.78e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—obesity	5.48e-07	4.72e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—obesity	5.46e-07	4.7e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—obesity	5.12e-07	4.41e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—obesity	5.04e-07	4.34e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—obesity	4.97e-07	4.28e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—obesity	4.58e-07	3.95e-06	CbGpPWpGaD
